Media Partners


The Molecular Medicine Tri-Conference has been and will continue to be a platform in recognizing the potential for new technologies and research in molecular medicine, diagnostics, drug discovery, and drug development that have a pivotal role in mitigating disease, improving access to healthcare, and identifying transformative treatments. The Molecular Medicine Tri-Conference offers a plenary keynote session on Monday from 5:00-6:00pm, Tuesday from 8:00-9:15am, and Wednesday from 8:00-10:00am. Join approximately 1,000 of your colleagues in each of these plenary keynote presentations. These are the only times each day that bring all attendees from all the conference programs together in one room.

Tuesday, March 12
8:00 - 9:15am

Data Science Enabling Personalized Medicine
Big data and machine learning have the potential to improve health, detecting disease at an earlier stage and personalizing interventions. The key ingredient, some say, is applying algorithms to population-wide datasets. But the question remains: is it enough to train smarter algorithms with broader datasets? What other approaches, diagnostics tools, and technologies do we need to accurately assess a patient’s unique needs and build a personalized intervention? A panel of experts across diagnostics, informatics, and therapeutics from government, academia, integrated health centers, data science, and biopharma will lead a highly interactive exploration of these issues and predict what it will take to realize the role of data science enabling personalized medicine.
Marty Tenenbaum, PhD, Founder and Chairman, Cancer Commons; Prominent AI Researcher; Cancer Survivor (Moderator)
Tanya Cashorali, Founder, TCB Analytics
Gaurav Kaushik, Associate Director, Data Products & Strategy, Foundation Medicine, Inc.
David Smoley, CIO, AstraZeneca
Additional Speakers to be Announced

Wednesday, March 13
8:00 - 10:00am

Plenary Session Panel: Emerging Technologies and Industry Perspectives
A popular session at Tri-Conference! This panel session will feature a series of short podium presentations on emerging and hot technologies in molecular medicine. Each speaker will have 7 minutes to present. After all speakers have presented, there will be a moderated Q&A with attendees. The presentations are not meant to be a corporate or specific product pitch. Each speaker will focus on a technology and solution framed around a motivational clinical problem and how their particular company/organization is solving it.
Joseph Krueger, CSO, Flagship Biosciences
Additional Speakers to be Announced